Leerink Partnrs Analysts Cut Earnings Estimates for Geron
Geron Co. (NASDAQ:GERN – Free Report) – Investment analysts at Leerink Partnrs lowered their Q3 2025 earnings estimates for shares of Geron in a research note issued on Wednesday, May 7th. Leerink Partnrs analyst F. Khurshid now anticipates that the biopharmaceutical company will post earnings of ($0.05) per share for the quarter, down from their […]
Geron Co. (NASDAQ:GERN – Free Report) – Investment analysts at Leerink Partnrs lowered their Q3 2025 earnings estimates for shares of Geron in a research note issued on Wednesday, May 7th. Leerink Partnrs analyst F. Khurshid now anticipates that the biopharmaceutical company will post earnings of ($0.05) per share for the quarter, down from their […]
